Dr. Praveen Vemula is a faculty at the Institute for Stem Cell Biology and Regenerative Medicine (inStem), in Bangalore, India.
A key focus of Vemula’s bioengineering laboratory is the development of platform technologies in the areas of biomaterials, drug delivery, and cell therapy to address unmet medical needs. In particular, Vemula and his team have been developing self-assembled hydrogels based biomaterials for clinical applications. He has been awarded many times with recognitions, including the prestigious Ewing Marion Kauffman Foundation, the MIT Business Plan Competitions. He has been a national topper to receive prestigious Ramalingaswami Re-Entry Fellowship from Department of Biotechnology, Government of India. His work has been highlighted in the print/electronic media including, CNN, Newsweek, the New York Times, Los Angeles Times, the Hindu, the Times of India and other. Prior to his current position, he has multiple years or research experience at the Harvard-MIT Division of Health Sciences and Technology, Brigham and Women’s Hospital. He previously conducted research in self-assembled materials at the City College of New York, which he joined after obtaining Ph.D. in Organic Chemistry from the Indian Institute of Science, India.
The Skintifique senior team
Dr. Jacques Delort
CEO and co-founder
Dr. Jeffrey Karp
Chair of the scientific committee and co-founder
Dr. Elisabeth Briand
Research and development
Digital and Marketing
Dr. Praveen Vemula
Skintifique is the ambitious project of two leading scientists, Dr. Jacques Delort, an entrepreneur and former medical science researcher, and Dr. Jeffrey Karp, a professor of medicine at Harvard Medical School and MIT. They met through their work and from there grew a friendship based on mutual respect, consolidated by their shared goal to harness scientific discoveries and approaches that improve everyone’s everyday life and health.
Medical, environmental or technological advances… we know that some areas of research require years and years of work before leading to concrete results.
Skintifique quickly expanded and Dr. Jacques Delort and Dr. Jeffrey Karp were joined by an enthusiastic team of brilliant scientists and experts from different backgrounds. They decided to pool their skills and values to make Skintifique a brand that’s always driven by the ambition to innovate and deliver the best possible solutions in well-being and dermatology. It is thanks to the commitment, passion and professionalism of the whole team that Skintifique’s innovation has been possible.
Just two years later came the Skintifique laboratory with the launch of the Protective Cream HPS, the world’s first product to protect skin against metals such as Nickel, Chromium or Cobalt. It was quickly followed by the revolutionary Hydrating Gel Plus HS, whose new and exclusive Activifique technology enables controlled and gradual release of the active ingredients for exceptional ongoing hydration and a tailored response, to the skin’s needs. This promising start for Skintifique continues to drive the development of future exciting products for skincare and medicine.
They talk about us
You have a question or a suggestion ?
Contact us via email, phone, online chat…